Cyclophosphamide Rx

Select the drug indication to add to your list

Cyclophosphamide

Breast cancer
CNS cancers
Eye cancer
Gynecologic cancers
Leukemias, lymphomas, and other hematologic cancers
Only 4 drugs may be compared at once

Generic Name and Formulations:

Cyclophosphamide 25mg, 50mg; tabs.

Select therapeutic use:

Indications for Cyclophosphamide:

Carcinoma of the breast.

Adult:

Initial and maintenance: 1–5mg/kg/day.

Children:

See full labeling.

Contraindications:

Severe bone marrow depression.

Warnings/Precautions:

Leukopenia. Thrombocytopenia. Tumor cell infiltration of bone marrow. Previous X-ray therapy or cytotoxic chemotherapy. Impaired renal or hepatic function. Infections. Adrenalectomy. General anesthesia within 10 days of therapy. Monitor hematologic profile (esp. neutrophils and platelets). Obtain urine sample (monitor for hemorrhagic cystitis); maintain adequate hydration. May interfere with wound healing. Elderly. Pregnancy (Cat.D). Nursing mothers: not recommended.

See Also:

Cyclophosphamide Injection

Pharmacological Class:

Alkylating agent.

Interactions:

Potentiated by phenobarbital. Potentiates other myelosuppressives, radiotherapy, succinylcholine. May potentiate doxorubicin-induced cardiotoxicity.

Adverse Reactions:

GI upset, alopecia, leukopenia, infections, thrombocytopenia, anemia, hemorrhagic cystitis (discontinue if occurs), renal tubular necrosis, interstitial pulmonary fibrosis, gonadal toxicity (amenorrhea, infertility), anaphylactic reactions.

Note:

Formerly known under the brand name Cytoxan.

How Supplied:

Contact supplier

Cyclophosphamide 50mg capsules (Qty:30)

appx. price $447.00

Indications for Cyclophosphamide:

Neuroblastoma (disseminated disease).

Adult:

Initial and maintenance: 1–5mg/kg/day.

Children:

See full labeling.

Contraindications:

Severe bone marrow depression.

Warnings/Precautions:

Leukopenia. Thrombocytopenia. Tumor cell infiltration of bone marrow. Previous X-ray therapy or cytotoxic chemotherapy. Impaired renal or hepatic function. Infections. Adrenalectomy. General anesthesia within 10 days of therapy. Monitor hematologic profile (esp. neutrophils and platelets). Obtain urine sample (monitor for hemorrhagic cystitis); maintain adequate hydration. May interfere with wound healing. Elderly. Pregnancy (Cat.D). Nursing mothers: not recommended.

See Also:

Cyclophosphamide Injection

Pharmacological Class:

Alkylating agent.

Interactions:

Potentiated by phenobarbital. Potentiates other myelosuppressives, radiotherapy, succinylcholine. May potentiate doxorubicin-induced cardiotoxicity.

Adverse Reactions:

GI upset, alopecia, leukopenia, infections, thrombocytopenia, anemia, hemorrhagic cystitis (discontinue if occurs), renal tubular necrosis, interstitial pulmonary fibrosis, gonadal toxicity (amenorrhea, infertility), anaphylactic reactions.

Note:

Formerly known under the brand name Cytoxan.

How Supplied:

Contact supplier

Cyclophosphamide 50mg capsules (Qty:30)

appx. price $447.00

Indications for Cyclophosphamide:

Retinoblastoma.

Adult:

Initial and maintenance: 1–5mg/kg/day.

Children:

See full labeling.

Contraindications:

Severe bone marrow depression.

Warnings/Precautions:

Leukopenia. Thrombocytopenia. Tumor cell infiltration of bone marrow. Previous X-ray therapy or cytotoxic chemotherapy. Impaired renal or hepatic function. Infections. Adrenalectomy. General anesthesia within 10 days of therapy. Monitor hematologic profile (esp. neutrophils and platelets). Obtain urine sample (monitor for hemorrhagic cystitis); maintain adequate hydration. May interfere with wound healing. Elderly. Pregnancy (Cat.D). Nursing mothers: not recommended.

See Also:

Cyclophosphamide Injection

Pharmacological Class:

Alkylating agent.

Interactions:

Potentiated by phenobarbital. Potentiates other myelosuppressives, radiotherapy, succinylcholine. May potentiate doxorubicin-induced cardiotoxicity.

Adverse Reactions:

GI upset, alopecia, leukopenia, infections, thrombocytopenia, anemia, hemorrhagic cystitis (discontinue if occurs), renal tubular necrosis, interstitial pulmonary fibrosis, gonadal toxicity (amenorrhea, infertility), anaphylactic reactions.

Note:

Formerly known under the brand name Cytoxan.

How Supplied:

Contact supplier

Cyclophosphamide 50mg capsules (Qty:30)

appx. price $447.00

Indications for Cyclophosphamide:

Adenocarcinoma of the ovary.

Adult:

Initial and maintenance: 1–5mg/kg/day.

Children:

See full labeling.

Contraindications:

Severe bone marrow depression.

Warnings/Precautions:

Leukopenia. Thrombocytopenia. Tumor cell infiltration of bone marrow. Previous X-ray therapy or cytotoxic chemotherapy. Impaired renal or hepatic function. Infections. Adrenalectomy. General anesthesia within 10 days of therapy. Monitor hematologic profile (esp. neutrophils and platelets). Obtain urine sample (monitor for hemorrhagic cystitis); maintain adequate hydration. May interfere with wound healing. Elderly. Pregnancy (Cat.D). Nursing mothers: not recommended.

See Also:

Cyclophosphamide Injection

Pharmacological Class:

Alkylating agent.

Interactions:

Potentiated by phenobarbital. Potentiates other myelosuppressives, radiotherapy, succinylcholine. May potentiate doxorubicin-induced cardiotoxicity.

Adverse Reactions:

GI upset, alopecia, leukopenia, infections, thrombocytopenia, anemia, hemorrhagic cystitis (discontinue if occurs), renal tubular necrosis, interstitial pulmonary fibrosis, gonadal toxicity (amenorrhea, infertility), anaphylactic reactions.

Note:

Formerly known under the brand name Cytoxan.

How Supplied:

Contact supplier

Cyclophosphamide 50mg capsules (Qty:30)

appx. price $447.00

Indications for Cyclophosphamide:

Malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt's lymphoma. Multiple myeloma. Leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia in children (cyclophosphamide given during remission is effective in prolonging its duration). Mycosis fungoides (advanced disease).

Adult:

Initial and maintenance: 1–5mg/kg/day.

Children:

See full labeling.

Contraindications:

Severe bone marrow depression.

Warnings/Precautions:

Leukopenia. Thrombocytopenia. Tumor cell infiltration of bone marrow. Previous X-ray therapy or cytotoxic chemotherapy. Impaired renal or hepatic function. Infections. Adrenalectomy. General anesthesia within 10 days of therapy. Monitor hematologic profile (esp. neutrophils and platelets). Obtain urine sample (monitor for hemorrhagic cystitis); maintain adequate hydration. May interfere with wound healing. Elderly. Pregnancy (Cat.D). Nursing mothers: not recommended.

See Also:

Cyclophosphamide Injection

Pharmacological Class:

Alkylating agent.

Interactions:

Potentiated by phenobarbital. Potentiates other myelosuppressives, radiotherapy, succinylcholine. May potentiate doxorubicin-induced cardiotoxicity.

Adverse Reactions:

GI upset, alopecia, leukopenia, infections, thrombocytopenia, anemia, hemorrhagic cystitis (discontinue if occurs), renal tubular necrosis, interstitial pulmonary fibrosis, gonadal toxicity (amenorrhea, infertility), anaphylactic reactions.

Note:

Formerly known under the brand name Cytoxan.

How Supplied:

Contact supplier

Cyclophosphamide 50mg capsules (Qty:30)

appx. price $447.00